Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 10/27/22 → 9/13/27 |
Financiación
- Novartis (domestic): 65.175,00 US$
Victorian-2 Prevent: A Randomized Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing The Impact of Inclisiran On Major Adverse Cardiovascular Events In Participants With Established Cardiovascular Disease
- Kotter, John (PI)